Once fatal, now curable: Story of infective endocarditis 'a miracle of medical progress'
Their paper explains that endocarditis was first reported during routine autopsies in the early 1800s, although it was several years before its bacterial cause was identified and a century before medicines were developed to fight the bacteria.
“Before the development of antibiotics, this disease was almost uniformly fatal,” Blair says. Surgery to remove infected tissue was occasionally helpful, but survival rates improved only after antibiotics were added.
The next breakthrough came in the 1970s with the development of a method of capturing ultrasound images of the beating heart.
This soon led to the practice of replacing damaged heart valves.
Today, patients who develop infective endocarditis receive antibiotics, often followed by valve replacement surgery.
Heart valves are susceptible to infection because they do not receive a blood supply of their own. For this reason, white blood cells and antibiotics, which fight infection, cannot reach the valves internally and must rely on the circulating blood to reach their targets.
Smulyan and Blair point out that infective endocarditis is a different disease now than when it was discovered two centuries ago. Different types of bacteria are responsible, and different types of patients are affected. Patients who develop this disease today are generally older and likely to have medical problems such as kidney disease or heart disease.
The doctors marvel at the progress made toward curing infective endocarditis. They write in their paper that although the infection can now be cured, prevention remains elusive.
This article appears in the fall 2016 issue of Upstate Health magazine. Click here for a radio interview/podcast with Smulyan and Blair about their research into infective endocarditis.